{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:50:00Z","timestamp":1789523400136,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd008300","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000}}],"reference-count":58,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008300.pub2","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T08:15:03Z","timestamp":1359447303000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treating BCG-induced disease in children"],"prefix":"10.1002","volume":"2019","author":[{"given":"Carlos A","family":"Cuello-Garc\u00eda","sequence":"first","affiliation":[{"name":"Escuela de Medicina-ITESM; Centre for Evidence Based Practice Tecnol\u00f3gico de Monterrey; Escuela de Medicina (CITES) piso 3 Avda. Morones Prieto 3000 pte. Col. Doctores Monterrey NL Mexico CP 64710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"P\u00e9rez-Gaxiola","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico de Sinaloa; Evidence-Based Practice Department; Blvd. Constituci\u00f3n s\/n, Col. Almada. 80200 Culiac\u00e1n Sinaloa Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jim\u00e9nez Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Perinatolog\u00eda; Subdirecci\u00f3n de Investigaci\u00f3n en Intervenciones Comunitarias; Montes Urales 800 Colonia Virreyes M\u00e9xico.DF DF Mexico Delegaci\u00f3n MIguel HIdalgo 11000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/adc.71.5.446","article-title":"Needle aspiration for suppurative post-BCG adenitis","volume":"71","author":"Banani","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"11","key":"10.1002\/14651858.CD008300.pub2-BIB0002|cit2","first-page":"1213","article-title":"Is medical therapy effective for regional lymphadenitis following BCG vaccination?","volume":"141","author":"Caglayan","year":"1987","journal-title":"American Journal of Diseases of Children"},{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/tropej\/31.5.286","article-title":"Management of BCG adenitis in infancy","volume":"31","author":"Close","year":"1985","journal-title":"Journal of Tropical Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00006454-199806000-00020","article-title":"Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guerin lymphadenitis","volume":"17","author":"Kuyucu","year":"1998","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD008300.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00006454-199302000-00006","article-title":"Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses","volume":"12","author":"Noah","year":"1993","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD008300.pub2-BIB0006|cit6","first-page":"135","article-title":"Analysis of the adverse effects occurring after the administration of BCG by oral route in 5,579 healthy children","volume":"82","author":"Amato Neto","year":"1973","journal-title":"Revista Paulista De Medicina"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/1097-0142(197806)41:6<2209::AID-CNCR2820410621>3.0.CO;2-P","article-title":"Pulmonary granulomas induced by BCG","volume":"41","author":"Au","year":"1978","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0008|cit8","first-page":"29","article-title":"Treatment of the suppurative BCG lymphadenitis","volume":"6","author":"Balkan","year":"1992","journal-title":"Pediatrik Cerrahi Dergisi"},{"issue":"388","key":"10.1002\/14651858.CD008300.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02759827","article-title":"Management of post-BCG lymphadenitis","volume":"47","author":"Bhandari","year":"1980","journal-title":"Indian Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1442-200X.1991.tb02593.x","article-title":"Management of suppuration in regional lymph nodes secondary to BCG vaccination","volume":"33","author":"Caglayan","year":"1991","journal-title":"Acta Paediatrica Japonica"},{"issue":"12","key":"10.1002\/14651858.CD008300.pub2-BIB0011|cit11","first-page":"569","article-title":"Lymphadenitis as a complication following vaccination with Bacillus Calmette-Gu\u00e9rin (BCG)","volume":"147","author":"Cerd\u00e1 de Palou","year":"2003","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0012|cit12","first-page":"45","article-title":"Epidemiological significance of the local reaction to direct BCG vaccination as assessed from a study in Mongolia","volume":"41","author":"Chavganc","year":"1969","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0013|cit13","first-page":"12","article-title":"Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae","volume":"65","author":"Britto","year":"1997","journal-title":"International journal of leprosy and other mycobacterial diseases"},{"issue":"3","key":"10.1002\/14651858.CD008300.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0041-3879(84)90077-1","article-title":"Lymphadenitis as a late complication of BCG vaccination","volume":"65","author":"Easton","year":"1984","journal-title":"Tubercle"},{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0962-8479(96)90123-9","article-title":"BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD","volume":"77","author":"Ferreira","year":"1996","journal-title":"Tubercle and Lung Disease"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00006454-200106000-00020","article-title":"Treatment of Calmette-Gu\u00e9rin bacillus adenitis: a metaanalysis","volume":"20","author":"Goraya","year":"2001","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"4947","key":"10.1002\/14651858.CD008300.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bmj.2.4947.1048","article-title":"Suppurative lymphadenitis following intradermal B.C.G. vaccination of the newborn; a preliminary report","volume":"2","author":"Guld","year":"1955","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD008300.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00006454-200204000-00026","article-title":"Dose of Calmette-Gu\u00e9rin bacillus vaccination in infants","volume":"21","author":"G\u00fcr","year":"2002","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"6473","key":"10.1002\/14651858.CD008300.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/bmj.290.6473.970","article-title":"Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination","volume":"290","author":"Hanley","year":"1985","journal-title":"British Medical Journal (Clinical research ed.)"},{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/PL00012279","article-title":"Surgical treatment of bacillus Calmette Gu\u00e9rin lymphadenitis","volume":"21","author":"Hengster","year":"1997","journal-title":"World\u00a0Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD008300.pub2-BIB0021|cit21","first-page":"431","article-title":"BCG vaccination and the subsequent development of cancer in humans","volume":"66","author":"Kendrick","year":"1981","journal-title":"Journal of the National Cancer Institute"},{"issue":"24","key":"10.1002\/14651858.CD008300.pub2-BIB0022|cit22","first-page":"1717","article-title":"Comparative study of 3 BCG vaccines","volume":"90","author":"Koivisto","year":"1974","journal-title":"Duodecim"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0023|cit23","first-page":"283","article-title":"Clinical aspect and therapy of BCG-lymphadenitis (author's transl)","volume":"11","author":"Lachmann","year":"1976","journal-title":"P\u00e4diatrie und P\u00e4dologie"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0024|cit24","first-page":"4","article-title":"BCG vaccination and increasing the effectiveness of treatment of post-vaccination complications by the use of rifampicin and dimexide","volume":"5","author":"Mitinskaia","year":"1994","journal-title":"Problemy Tuberkuleza"},{"issue":"4","key":"10.1002\/14651858.CD008300.pub2-BIB0025|cit25","first-page":"16","article-title":"Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management","volume":"17","author":"Nazir","year":"2005","journal-title":"Journal of Ayub Medical College, Abbottabad: JAMC"},{"issue":"10","key":"10.1002\/14651858.CD008300.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006454-199210000-00016","article-title":"Treatment of Bacillus Calmette-Gu\u00e9rin-associated lymphadenitis","volume":"11","author":"O\u011fuz","year":"1992","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"9","key":"10.1002\/14651858.CD008300.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5588\/ijtld.10.0721","article-title":"Early antiretroviral treatment reduces risk of bacille Calmette-Gu\u00e9rin immune reconstitution adenitis","volume":"15","author":"Rabie","year":"2011","journal-title":"The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"11","key":"10.1002\/14651858.CD008300.pub2-BIB0028|cit28","first-page":"1719","article-title":"Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran","volume":"27","author":"Samileh","year":"2006","journal-title":"Saudi Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD008300.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0264-410X(91)90040-D","article-title":"Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana","volume":"9","author":"Teulieres","year":"1991","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"F64","DOI":"10.1136\/fn.81.1.F64","article-title":"Safety and effectiveness of BCG vaccination in preterm babies","volume":"81","author":"Thayyil-Sudhan","year":"1999","journal-title":"Archives of Disease in Childhood. Fetal and neonatal edition"},{"issue":"3","key":"10.1002\/14651858.CD008300.pub2-BIB0031|cit31","first-page":"226","article-title":"Study on different treatment methods of tuberculous lymphadenitis caused by BCG vaccination","volume":"18","author":"Yuan","year":"2001","journal-title":"Journal of Clinical Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008300.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/adc.2005.078972","article-title":"Complications associated with the bacille Calmette-Gu\u00e9rin vaccination in Ireland","volume":"91","author":"Bolger","year":"2006","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD008300.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2105\/AJPH.83.4.583","article-title":"Complications of BCG vaccinations in rural Haiti","volume":"83","author":"Bonnlander","year":"1993","journal-title":"American Journal of Public Health"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.inf.0000164769.22033.2c","article-title":"Serious adverse events associated with Bacille Calmette-Gu\u00e9rin vaccine in Canada","volume":"24","author":"Deeks","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0035|cit35","unstructured":"Fine P Carneiro I Milstein JB Clements CJ BCG immunization policies. Issues relating to the use of BCG in immunisation programmes Geneva: World Health Organization (WHO\/V&B\/99.23) 1999"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD008300.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1086\/314074","article-title":"Management of adverse reactions to Bacille Calmette-Gu\u00e9rin vaccine","volume":"31","author":"Fitzgerald","year":"2000","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja12.10089","article-title":"Immune reconstitution inflammatory syndrome: immune restoration disease 20 years on","volume":"196","author":"French","year":"2012","journal-title":"The Medical Journal of Australia"},{"issue":"920","key":"10.1002\/14651858.CD008300.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/pmj.78.920.327","article-title":"Bacille Calmette-Gu\u00e9rin lymphadenitis","volume":"78","author":"Goraya","year":"2002","journal-title":"Postgraduate Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD008300.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/adc.2011.214494","article-title":"Prospects for elimination of childhood tuberculosis: the role of new vaccines","volume":"96","author":"Hatherill","year":"2011","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD008300.pub2-BIB0040|cit40","first-page":"503","article-title":"Drug resistance in the Swedish\/Norwegian BCG strain","volume":"46","author":"Hesselberg","year":"1972","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"10.1002\/14651858.CD008300.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.inf.0000126593.21006.ac","article-title":"Resistant Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin disease: implications for management of Bacillus Calmette-Gu\u00e9rin Disease in human immunodeficiency virus-infected children","volume":"23","author":"Hesseling","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD008300.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","article-title":"Bacille Calmette-Gu\u00e9rin Vaccine-Induced Disease in HIV-Infected and HIV-Uninfected Children","volume":"42","author":"Hesseling","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0044|cit44","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Assessing risk of bias in included studies Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. 2011"},{"issue":"10","key":"10.1002\/14651858.CD008300.pub2-BIB0045|cit45","first-page":"801","article-title":"Surgical complications of bacille Calmette-Gu\u00e9rin (BCG) infection in HIV-infected children: Time for a change in policy?","volume":"98","author":"Karpelowsky","year":"2008","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0046|cit46","first-page":"107","article-title":"BCG complications: estimates of risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Advances in Tuberculosis Research"},{"issue":"2","key":"10.1002\/14651858.CD008300.pub2-BIB0047|cit47","first-page":"47","article-title":"Second IUATLD study on complications induced by intradermal BCG vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bulletin of the International Union Against Tuberculosis and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0048|cit48","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0049|cit49","unstructured":"Milstien JB Immunological Basis for Immunization \/ Module 5: Tuberculosis (WHO\/EPI\/GEN\/93.15). Geneva: World Health Organization 1993"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"712736","DOI":"10.1155\/2011\/712736","article-title":"BCG Vaccination in HIV-Infected Children","volume":"2011","author":"Nuttall","year":"2011","journal-title":"Tuberculosis Research and Treatment"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.ijid.2008.06.014","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy","volume":"12","author":"Nuttall","year":"2008","journal-title":"International Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008300.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1542\/peds.95.3.414","article-title":"Bacillus Calmette-Gu\u00e9rin complications in children born to HIV-1-infected women with a review of the literature","volume":"95","author":"O'Brien","year":"1995","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008300.pub2-BIB0053|cit53","unstructured":"Rabie H Violari A Madhi S Gibb D Steyn J van Niekerk R Complications of BCG Vaccination in HIV-infected and uninfected Children: CHER Study. Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections Boston Foundation for Retrovirology and Human Health 2008"},{"issue":"1","key":"10.1002\/14651858.CD008300.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD008300.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/thx.38.11.806","article-title":"BCG: who were Calmette and Gu\u00e9rin?","volume":"38","author":"Sakula","year":"1983","journal-title":"Thorax"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4103\/0971-5916.92632","article-title":"HIV & immune reconstitution inflammatory syndrome (IRIS)","volume":"134","author":"Sharma","year":"2011","journal-title":"The Indian Journal of Medical Research"},{"issue":"6","key":"10.1002\/14651858.CD008300.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Gu\u00e9rin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"21","key":"10.1002\/14651858.CD008300.pub2-BIB0058|cit58","first-page":"193","article-title":"Revised BCG vaccination guidelines for infants at risk for HIV infection","volume":"82","author":"World Health Organization","year":"2007","journal-title":"The Weekly Epidemiological Record"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008300.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T20:01:57Z","timestamp":1746993717000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008300.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008300.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985632.793473387","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}